Back to results
US 9,339,480 B2Granted
Bile acid recycling inhibitors for treatment of obesity and diabetes
AssigneeSatiogen Pharmaceuticals, Inc.
InventorsAndrew A. Young, Bronislava Gedulin, Howard E. Greene
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of utilizing bile acid transport inhibitors for the treatment of obesity and diabetes.
Claims23
A method for treating diabetes comprising administering to the distal ileum, the colon, or the rectum of a diabetic individual, a pharmaceutical composition consisting essentially of a therapeutically effective amount of:
- (1) an Apical Sodium-dependent Bile Transporter Inhibitor (ASBTI) and (2) a DPP-IV inhibitor.
A method for treating diabetes comprising administering to the distal ileum, the colon, or the rectum of a diabetic individual, a pharmaceutical composition consisting essentially of a therapeutically effective amount of:
- (1) a non-systemically absorbed Apical Sodium-dependent Bile Transporter Inhibitor (ASBTI) and (2) a DPP-IV inhibitor.
Dependencies are inferred from the claim text.